🟢 Picard Medical is trading 7% up in pre-market with no clear catalyst identified

Picard Medical is trading at $7.92, up 7.46% before the October 23, 2026, open, with no clear company-specific catalyst identified.

• The October 22 session ended down 23.47%.
• A recent SEC prospectus registered up to 500,000 shares for resale, including shares tied to convertible notes and warrants; available reporting does not establish it as the reason for the rebound.
• Market context is mixed and does not clearly explain the gain; trading volume is unavailable.